|Videos|May 2, 2017

What Can the Ebola Outbreak Teach Us About Managing Zika?

Jean-Paul Gonzalez, MD, PhD, Deputy Director, Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Kansas State University, Adjunct Professor, Kansas State University, discusses the parallels between past Ebola outbreaks, and how they can help us manage the current Zika pandemic.

Jean-Paul Gonzalez, MD, PhD, Deputy Director, Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Kansas State University, Adjunct Professor, Kansas State University, discusses the parallels between past Ebola outbreaks, and how they can help us manage the current Zika pandemic.

Interview Transcript (slightly modified for readability)

“Ebola is kind of an exemplary disease [for the management of Zika]. Ebola, again like Zika, came out from the darkness of the forest and emerged close to a village, or city, in central Africa. It was circulating as [was] Zika [without any notice] for years and years, probably for at least a century in the forest, and then emerged [as a threat] in 1976. But imagine, for 20 years the Ebola virus did not show up. It was circulating [in a] cryptic [manner], hiding in its natural cycle, and then we have this successive outbreak of Ebola.

What we learned from Ebola, [is] we learned to be ready. We learned [this] too late during this late outbreak in West Africa, but we learned to be prepared, be responsive, be ready [for] any type of outbreak in the middle of nowhere. So, this is what we learned, and this is a type of lesson we [have that we can use] to now fight the Zika virus. But the scale of the severity of the Zika virus, the severity [when comparing] Ebola and Zika is totally different. [With Zika] we are facing a rapid pandemic extension of the virus. This is kind of parallel, [as] I said, [with] Ebola, but all the viruses are acting like that.

The reason Zika is a model now for us is that it’s an arbovirus, so it’s associated with mosquitoes, [which] are everywhere. This is a very important pattern of this pandemic of Zika now, because the vector reservoir now is a mosquito.”


Related to this article

Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
FAQ: Ebola Prevention, Treatment and the Chances of a US Outbreak
As the Bundibugyo virus outbreak in the Democratic Republic of the Congo surpasses 9300 confirmed cases and 4400 deaths, this FAQ explains how the virus spreads, how it presents, why it is hard to diagnose and treat, which vaccines and therapies are being tested, and why CDC considers the risk to the United States low.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.